Accretive Health, Inc. 4
4 · Accretive Health, Inc. · Filed Jul 2, 2014
Insider Transaction Report
Form 4
Nayden Denis
Director
Transactions
- Award
Director Stock Option (right to buy)
2014-07-01$4.01/sh+3,743$15,009→ 3,743 totalExercise: $8.00From: 2014-07-01Exp: 2024-07-01→ Common Stock (3,743 underlying)
Footnotes (1)
- [F1]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.